ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
BLU INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BELLUS Health, Inc. Biotech Investing
MagicMed’s Natalie Dolphin: PsyAI™ Designed to Streamline Pharmaceutical Design Pharmaceutical Investing
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against BELLUS Health Inc. Biotech Investing
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BELLUS Health Inc. Investors Biotech Investing
BLU Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BELLUS Health Inc. Investors of Class Action and Encourages Investors to Contact the Firm Biotech Investing
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy Biotech Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV Biotech Investing
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Deadline - BLU Biotech Investing
Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day Biotech Investing
